A disruptor to Precision Medicine and Nutrition through biomarker discovery.
InSyBio Precision Chronic Pain Treatment
Identify the best chronic pain non-opioid treatment for you.
Preprocessing and analysis for proteomics and interactomics biological data.
Analysis of non-coding RNA molecules.
Biomarkers discovery on biological networks.
Apply predictive analytics on multi-omics data with InSyBio Biomarkers.
Pre-processing and Analysis of DNA-sequencing Data.
Optimized and Automatized Biomarker Discovery & Processing of Biomedical Data.
Storing and managing biological datasets.
Pay Upon Success BioData Analysis Services
Expediting your Biodata Analysis & Outcome Prediction Modelling Process.
InSyBio Personalization Test
Building personalized tests faster, more accurate and using low sample size studies.
Dietary and nutritional products affect individuals differently based on their genetic predisposition, nutritional lifestyle, exercises habits, and their environments.
Clinical Trials: Targeted patient stratification to speed up the process and reduce the risk of failures in trials
More than 50% of clinical trials currently fail due to low efficacy.
Several markers and tests have been introduced in the market for diagnosing cancer types and other diseases.
Preclinical research, when related to molecular biology data analysis, mostly includes statistical analysis to identify significantly differentiated molecules in the phenotypes under study.
Publishing scientific findings in domain-specific journals and announcing them in scientific conferences has become an essential part of today’s research environment.